View in EDS

Capturing "source" and "evolution": A 5-year recurrence risk prediction model for nasopharyngeal carcinoma based on integrated radiomic spatial heterogeneity of primary tumor and lymph nodes.

Saved in:
Bibliographic Details
Title: Capturing "source" and "evolution": A 5-year recurrence risk prediction model for nasopharyngeal carcinoma based on integrated radiomic spatial heterogeneity of primary tumor and lymph nodes.
Authors: Wang C; Department of Radiation Oncology, Affiliated Cancer Hospital of Nanjing Medical University, & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, Jiangsu, China., Wang W; Department of Radiation Oncology, Affiliated Cancer Hospital of Nanjing Medical University, & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, Jiangsu, China., Zong D; Department of Radiation Oncology, Affiliated Cancer Hospital of Nanjing Medical University, & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, Jiangsu, China., Ding M; Department of Radiation Oncology, Affiliated Cancer Hospital of Nanjing Medical University, & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, Jiangsu, China; Radiotherapy Department, The Affiliated Changzhou NO. 2 People's Hospital of Nanjing Medical University, Changzhou 213000, China., Han L; Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China., Zhang J; Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan 250117, China., Hu S; Department of Radiation Oncology, Yantai Yuhuangding Hospital, Yantai 264000, Shandong, China., Cao X; Department of Radiation Oncology, Affiliated Cancer Hospital of Nanjing Medical University, & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, Jiangsu, China., Ge Y; Department of Radiation Oncology, Affiliated Cancer Hospital of Nanjing Medical University, & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, Jiangsu, China., Zhu C; Department of Radiation Oncology, Affiliated Cancer Hospital of Nanjing Medical University, & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, Jiangsu, China., He X; Department of Radiation Oncology, Affiliated Cancer Hospital of Nanjing Medical University, & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, Jiangsu, China. Electronic address: hexiabm@163.com.
Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2026 Jul; Vol. 220, pp. 111552. Date of Electronic Publication: 2026 Apr 28.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0887
DOI:10.1016/j.radonc.2026.111552